Breaking News Instant updates and real-time market news.

HSKA

Heska

$108.14

-0.49 (-0.45%)

08:38
07/19/18
07/19
08:38
07/19/18
08:38

Heska transferred with a Buy at Benchmark

Benchmark transferred coverage of Heska to analyst Bruce Jackson, who has a Buy rating and $120 price target on the shares. Heska has grown its share of the veterinary diagnostics market to 10% from 3% during the past five year, giving it a 2,000 account subscriber base that is an "engine for long-term cash flow generation," said Jackson, who also notes that the company plans to take its business model to international markets.

HSKA Heska
$108.14

-0.49 (-0.45%)

05/07/18
ADAM
05/07/18
NO CHANGE
Target $100
ADAM
Buy
Heska price target raised to $100 from $95 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Heska (HSKA) to $100 from $95 and said he is a buyer of the shares ahead of its analyst day. He cited several reasons, including the company's intention to work with partner Henry Schein (HSIC) outside the U.S., expectations for new product announcements, and details about its global expansion initiatives. Massaro reiterated his Buy rating on Heska shares.
05/18/18
ADAM
05/18/18
NO CHANGE
Target $115
ADAM
Buy
Heska price target raised to $115 from $100 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Heska to $115 from $100 following its analyst day. He cited expectations for new products, new markets, and the company's plan for growth into 2022. Massaro reiterated his Buy rating on Heska shares.
05/21/18
BNCH
05/21/18
NO CHANGE
Target $120
BNCH
Buy
Heska price target raised to $120 following management meetings at Benchmark
After meeting with meetings with Heska (HSKA) management, Benchmark analyst Raymond Myers came away with a better understanding of how current investments are likely to accelerate future cash flows and how its new products and international expansion can accelerate revenue growth in 2019. He also said Zoetis' (ZTS) deal to acquire Abaxis (ABAX) "puts a high price tag on Heska," estimating that valuing Heska on the same terms as Abaxis would imply a valuation of $143 per Heska share. Myers raised his price target on Heska to $120 from $100 and keeps a Buy rating on the shares.
06/15/18
ADAM
06/15/18
NO CHANGE
Target $123
ADAM
Buy
Heska price target raised to $123 from $115 at Canaccord
After Heska (HSKA) announced after the close a contract win to supply in-clinic diagnostic equipment and supplies to Pathway Vet Alliance, Canaccord analyst Mark Massaro said management confirmed that the multi-year deal was a competitive win, mostly from Idexx (IDXX). He sees the deal positioning Heska for upside in 2019 and 2020 and raised his price target on the stock to $123 from $115. Massaro keeps a Buy rating on Heska shares.

TODAY'S FREE FLY STORIES

SINA

Sina

$42.56

-4.94 (-10.40%)

05:45
05/24/19
05/24
05:45
05/24/19
05:45
Downgrade
Sina rating change  »

Sina downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$15.57

-0.29 (-1.83%)

05:44
05/24/19
05/24
05:44
05/24/19
05:44
Upgrade
Vodafone rating change  »

Vodafone upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SR

Spire

$85.92

0.26 (0.30%)

05:43
05/24/19
05/24
05:43
05/24/19
05:43
Downgrade
Spire rating change  »

Spire downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

VEEV

Veeva

$140.80

-3.74 (-2.59%)

05:43
05/24/19
05/24
05:43
05/24/19
05:43
Downgrade
Veeva rating change  »

Veeva downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

VALE

Vale

$11.78

0.03 (0.26%)

05:41
05/24/19
05/24
05:41
05/24/19
05:41
Upgrade
Vale rating change  »

Vale upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STZ

Constellation Brands

$206.21

0.96 (0.47%)

05:39
05/24/19
05/24
05:39
05/24/19
05:39
Downgrade
Constellation Brands rating change  »

Constellation Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$276.46

-1.35 (-0.49%)

05:39
05/24/19
05/24
05:39
05/24/19
05:39
Downgrade
Lennox rating change  »

Lennox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

TOO

Teekay Offshore Partners

$1.11

0.005 (0.45%)

, BBU

Brookfield Business Partners

$37.63

-0.43 (-1.13%)

05:36
05/24/19
05/24
05:36
05/24/19
05:36
Hot Stocks
JDP finds support from other Teekay Offshore holders to oppose Brookfield deal »

On May 17, Brookfield…

TOO

Teekay Offshore Partners

$1.11

0.005 (0.45%)

BBU

Brookfield Business Partners

$37.63

-0.43 (-1.13%)

TK

Teekay Corp.

$3.86

-0.35 (-8.31%)

BAM

Brookfield

$46.55

-0.25 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 08

    Aug

NGLOY

Anglo American

$0.00

(0.00%)

05:33
05/24/19
05/24
05:33
05/24/19
05:33
Upgrade
Anglo American rating change  »

Anglo American upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

05:29
05/24/19
05/24
05:29
05/24/19
05:29
Downgrade
Weibo rating change  »

Weibo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$276.46

-1.35 (-0.49%)

05:28
05/24/19
05/24
05:28
05/24/19
05:28
Downgrade
Lennox rating change  »

Lennox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

GMED

Globus Medical

$40.59

-0.84 (-2.03%)

05:26
05/24/19
05/24
05:26
05/24/19
05:26
Downgrade
Globus Medical rating change  »

Globus Medical downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

BCRX

BioCryst

$3.54

0.09 (2.61%)

05:25
05/24/19
05/24
05:25
05/24/19
05:25
Downgrade
BioCryst rating change  »

BioCryst downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

MRBK

Meridian Bank

$16.95

(0.00%)

05:25
05/24/19
05/24
05:25
05/24/19
05:25
Earnings
Meridian reports Q1 EPS 31c, consensus 22c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$282.19

-3.43 (-1.20%)

05:24
05/24/19
05/24
05:24
05/24/19
05:24
General news
U.K. Prime Minister Theresa May announces she'll step down on June 7 »

In a public address,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$282.19

-3.43 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$67.13

-1.42 (-2.07%)

05:20
05/24/19
05/24
05:20
05/24/19
05:20
Recommendations
Ionis Pharmaceuticals analyst commentary  »

Piper 'incrementally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

ADSK

Autodesk

$169.64

-4.47 (-2.57%)

05:14
05/24/19
05/24
05:14
05/24/19
05:14
Recommendations
Autodesk analyst commentary  »

Autodesk Q1 results did…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jun

  • 12

    Jun

SPLK

Splunk

$128.68

-7.12 (-5.24%)

05:10
05/24/19
05/24
05:10
05/24/19
05:10
Recommendations
Splunk analyst commentary  »

Splunk exceeded most…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 09

    Jul

AMZN

Amazon.com

$1,815.30

-42.44 (-2.28%)

05:06
05/24/19
05/24
05:06
05/24/19
05:06
Recommendations
Amazon.com analyst commentary  »

Amazon shares will rally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 25

    Jun

AAXN

Axon

$67.06

-1.29 (-1.89%)

04:58
05/24/19
05/24
04:58
05/24/19
04:58
Downgrade
Axon rating change  »

Axon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

KTB

Kontoor Brands

$38.51

0.82 (2.18%)

, ORN

Orion Group

$1.87

-0.12 (-6.03%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Hot Stocks
Kontoor Brands to replace Orion Group in S&P 600 at open on 5/24 »

V.F. Corp. (VFC) is…

KTB

Kontoor Brands

$38.51

0.82 (2.18%)

ORN

Orion Group

$1.87

-0.12 (-6.03%)

VFC

VF Corp.

$84.06

-6.32 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

04:55
05/24/19
05/24
04:55
05/24/19
04:55
General news
Breaking General news story  »

Week of 5/24 Baker-Hughes…

QGEN

Qiagen

$38.48

-0.235 (-0.61%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Qiagen participates in a conference call with JPMorgan »

Life Science &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AEL

American Equity

$28.63

-1.25 (-4.18%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
American Equity participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 06

    Jun

TWI

Titan International

$4.47

-0.125 (-2.72%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Titan International management to meet with SIdoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.